National, Longitudinal, Multicentre and Prospective, Observational Study of the Use of Micafungin (Mycamine) in Antifungal Prophylaxis of Invasive Fungal Infections in Medical Practice in Haematology and Onco-haematology

Trial Profile

National, Longitudinal, Multicentre and Prospective, Observational Study of the Use of Micafungin (Mycamine) in Antifungal Prophylaxis of Invasive Fungal Infections in Medical Practice in Haematology and Onco-haematology

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jun 2017

At a glance

  • Drugs Micafungin (Primary)
  • Indications Mycoses
  • Focus Therapeutic Use
  • Acronyms OLYMPE
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association.
    • 01 Jun 2016 Status changed from recruiting to completed.
    • 09 Jul 2015 Planned End Date changed from 1 Oct 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top